中性粒细胞通过成纤维细胞生长因子2依赖性血管生成促进小鼠肝转移瘤生长
该研究在小鼠实验性肝转移模型中观察到,已建立的肝转移灶被中性粒细胞浸润,清除中性粒细胞可减少转移灶生长并降低血管密度和分支,提示血管正常化。转移相关中性粒细胞表达的成纤维细胞生长因子2(FGF2)显著高于初始中性粒细胞,给予FGF2中和抗体可重现中性粒细胞清除的效果,减少肝转移集落生长、血管密度和分支。
要点
- 小鼠已建立的肝转移灶中清除中性粒细胞可减少转移灶生长,并降低血管密度和分支。
- 转移相关中性粒细胞表达的FGF2显著高于初始中性粒细胞,提示肿瘤微环境使中性粒细胞极化。
- 给予FGF2中和抗体可重现中性粒细胞清除的效果,减少肝转移集落生长、血管密度和分支。
核心结论
- 以FGF2为例,识别介导浸润髓系细胞促肿瘤作用的因子可用于靶向已建立的肝转移灶。
- 此类治疗或可限制疾病进展并增强标准消融治疗的效果。
研究设计与样本
- 研究为小鼠实验性肝转移模型研究,观察人结直肠癌肝转移和鼠胃肠道实验性肝转移中的中性粒细胞浸润。
- 在已建立的鼠实验性肝转移中清除中性粒细胞,并给予FGF2中和抗体,评估转移灶生长及血管密度和分支。
主要发现
- 已建立的鼠实验性肝转移中,清除中性粒细胞导致转移灶生长减少,并伴随血管密度和分支减少,提示血管正常化。
- 转移相关中性粒细胞表达的FGF2显著高于初始中性粒细胞,提示肿瘤微环境使中性粒细胞极化。
- 给予FGF2中和抗体可重现中性粒细胞清除的效果,减少肝转移集落生长、血管密度和分支。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatic metastases are amenable to ablation; however, many patients are not suitable candidates for such therapy and recurrence is common. The tumor microenvironment is known to be essential for metastatic growth, yet identification of plausible targets for cancer therapy in the microenvironment has proven elusive. We found that human colorectal cancer liver metastases and murine gastrointestinal experimental liver metastases are infiltrated by neutrophils. Plasticity in neutrophils has recently been shown to lead to both protumor and antitumor effects. Here, neutrophils promoted the growth of hepatic metastases, given that depletion of neutrophils in already established, experimental, murine liver metastases led to diminished metastatic growth. Decreased growth was associated with reductions in vascular density and branching suggestive of vessel normalization. Metastasis-associated neutrophils expressed substantially more fibroblast growth factor 2 (FGF2) than naïve neutrophils, indicating neutrophil polarization by the tumor microenvironment. Administration of FGF2 neutralizing antibody to mice bearing experimental liver metastases phenocopied neutrophil depletion by reducing liver metastatic colony growth, vascular density, and branching. CONCLUSION: Here, we show, using FGF2 as an example, that identification of factors responsible for the protumoral effects of infiltrating myeloid cells can be used to target established liver metastases. Such therapies could be utilized to limit disease progression and potentiate the effects of standard ablative therapies. (Hepatology 2017;65:1920-1935).
引用
- Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice. Hepatology. 2017. PMID: 28133764. doi:10.1002/hep.29088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。